Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
DV3-MEL-01
Clinical Trial Grant
Duke Scholars
Principal Investigator
April Kelly Scott Salama
Medicine, Medical Oncology
Administered By
Duke Cancer Institute
Awarded By
Dynavax Technologies Corporation
Start Date
March 14, 2017
End Date
April 21, 2020
Administered By
Duke Cancer Institute
Awarded By
Dynavax Technologies Corporation
Start Date
March 14, 2017
End Date
April 21, 2020
